EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: 3-Month Results

W Grant Stevens iD, Jeremy B Green, Craig Layt, Michael S Kaminer, Jennifer Harrington, Larry Fan, Holly Wall, Sabrina Fabi, Mark R Magnusson iD

Aesthetic Surgery Journal · 2023

DOI: 10.1093/asj/sjac179 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Aesthetic Surgery Journal, 2023. Verfasst von W Grant Stevens und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Southern California, Keck School of Medicine, Marina del Rey, CA, USA. Hauptthemen laut MEDLINE: Patient Satisfaction, Cellulite. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Revelle Aesthetics, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cellulite is an aesthetic condition affecting the appearance of skin in certain body regions and is associated with body dissatisfaction, psychosocial stress, and decreased quality of life. Previous studies established the safety and feasibility of a novel, minimally invasive device to identify and release septa responsible for cellulite depressions: targeted verifiable subcision (TVS).

Objectives

The objective of this single-arm, open-label, multicenter study was to evaluate the safety and efficacy of TVS for reducing the appearance of moderate to severe cellulite in adult women.

Methods

Adult women aged 21 to 55 years and a BMI < 30 kg/m2 with moderate or severe cellulite on the buttocks and/or thighs were eligible to enroll at 9 sites. Endpoint data included results from 4 of the postprocedural follow-up visits at 24 hours, 7 days, 30 days, and 90 days. The primary endpoints were a mean ≥1 point reduction in the Cellulite Severity Scale at 90 days and no related serious adverse events at 30 days.

Results

Seventy-four female participants with a mean BMI of 24.8 ± 2.7 and age of 41.4 ± 7.4 years received this single procedure. The mean improvement in Cellulite Severity Scale (N = 68) was 1.5 ± 0.9 (P < 0.0001). There were no device-related serious adverse events at 30 days.

Conclusions

TVS for selectively identifying and verifiably releasing septa responsible for cellulite depressions is an effective and safe means to improve the appearance of moderate to severe cellulite in adult women. Level of Evidence: 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient SatisfactionCelluliteAdultFemaleHumansTreatment OutcomeQuality of LifeButtocksThigh

Autor:innen und Institutionen

  • University of Southern California, Keck School of Medicine, Marina del Rey, CA, USA.
  • Griffith University, School of Medicine, Southport, Queensland, Australia and is an international editor for Aesthetic Surgery Journal.

ORCID-Profile: W Grant Stevens, Mark R Magnusson

Förderung

  • Revelle Aesthetics, Inc

Zitieren

APA

Stevens, W. G., Green, J. B., Layt, C., Kaminer, M. S., Harrington, J., Fan, L., Wall, H., Fabi, S., & Magnusson, M. R. (2023). Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: 3-Month Results. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjac179

Vancouver

Stevens WG, Green JB, Layt C, Kaminer MS, Harrington J, Fan L, et al. Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: 3-Month Results. Aesthetic Surgery Journal. 2023. doi:10.1093/asj/sjac179

BibTeX
@article{Stevens2023,
  author = {Stevens, W Grant and Green, Jeremy B and Layt, Craig and Kaminer, Michael S and Harrington, Jennifer and Fan, Larry and Wall, Holly and Fabi, Sabrina and Magnusson, Mark R},
  title = {Multicenter Pivotal Study Demonstrates Safety and Efficacy of a New Cellulite Procedure: 3-Month Results},
  journal = {Aesthetic Surgery Journal},
  year = {2023},
  doi = {10.1093/asj/sjac179}
}
Kostenlos starten →